Venture Capital

Updated:

RenalGuard

CardioRenal Systems, Inc. is a medical device company that focuses on preventing acute kidney injury (AKI). Its primary product is the RenalGuard/RenalPro...

RenalGuard

CardioRenal Systems, Inc. is a medical device company that focuses on preventing acute kidney injury (AKI). Its primary product is the RenalGuard/RenalPro closed-loop hydration system, used in cardiac surgery and interventional procedures. The firm is headquartered in Menlo Park, United States.

General information

Firm type

Medical Equipment Manufacturing

Location

Region

North America

Country

United States

City

Menlo Park

Corporate office

Menlo Park, United States

Sector focus

Venture CapitalMedical Equipment ManufacturingUnited States

Frequently asked questions

What is the primary focus of CardioRenal Systems, Inc.?

CardioRenal Systems, Inc. focuses on technologies to prevent acute kidney injury (AKI).

What is the main product offered by CardioRenal Systems, Inc.?

The main product is the RenalGuard/RenalPro closed-loop hydration system, used in cardiac surgery and interventional procedures.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Menlo Park Medical Equipment Manufacturing profiles